Revisiting the strategies for the pharmacological management of type 2 diabetes – From glycemic control, organ protection, safety to weight reduction-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Revisiting the strategies for the pharmacological management of type 2 diabetes – From glycemic control, organ protection, safety to weight reduction

Published:2021-12-14 Issue:1 Volume:13 Page:3-5
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J of Diabetes Invest

Author:

Li Hung‐Yuan¹^ORCID

Affiliation:

1. Division of Endocrinology and Metabolism Department of Internal Medicine National Taiwan University Hospital Taipei Taiwan

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdi.13726

Reference5 articles.

1. Improvement of glycemic control and reduction of major cardiovascular events in 18 cardiovascular outcome trials: an updated meta-regression

2. 10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

3. Intensive glucose control and macrovascular outcomes in type 2 diabetes

4. Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation

5. Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy of switching basal–bolus insulin therapy to basal insulin-supported oral therapy with a glinide and an α-glucosidase inhibitor in patients with type 2 diabetes depends on insulin secretory capacity, but not on blood glucose profiles and insulin dosages prior to the switching;Diabetology International;2023-09-04

2. Updates of incretin‐related drugs for the treatment of type 2 diabetes;Journal of Diabetes Investigation;2022-11-14

3. Comparison of Sodium-Glucose Cotransporter 2 Inhibitors vs Glucagonlike Peptide-1 Receptor Agonists and Incidence of Dry Eye Disease in Patients With Type 2 Diabetes in Taiwan;JAMA Network Open;2022-09-22

4. Neuroprotective Effect of 3′,4′-Dihydroxyphenylglycol in Type-1-like Diabetic Rats—Influence of the Hydroxytyrosol/3′,4′-dihydroxyphenylglycol Ratio;Nutrients;2022-03-08

5. Once-weekly 2.4 mg Semaglutide for Weight Management in Obesity: A Game Changer?;Endocrinology;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3